
Health
AIIMS trial of mRNA cancer therapy shows early response in solid tumours
A small phase-one cohort reports promising immune activation with a tolerable side-effect profile.
Medical research, public health and reporting from clinics and communities.

Coverage now spans gene therapies for spinal muscular atrophy.

City hospitals report a 30 percent rise over the last two weeks.












Sign up for the Daily Kiran — our morning briefing on politics, business and sport.